PDF herunterladen
Diabetes aktuell 2022; 20(01): 36-42
DOI: 10.1055/a-1753-3875
Schwerpunkt

Metabolische und mentale Folgen der Pandemie

Zeit zu Handeln
Charlotte Steenblock
1   Medizinische Klinik und Poliklinik III, Universitätsklinikum Carl Gustav Carus Dresden
,
Christian Ziegler
1   Medizinische Klinik und Poliklinik III, Universitätsklinikum Carl Gustav Carus Dresden
,
Wladimir Balanzew
1   Medizinische Klinik und Poliklinik III, Universitätsklinikum Carl Gustav Carus Dresden
,
Andreas Barthel
1   Medizinische Klinik und Poliklinik III, Universitätsklinikum Carl Gustav Carus Dresden
2   Medicover Bochum MVZ
,
Jun Wang
1   Medizinische Klinik und Poliklinik III, Universitätsklinikum Carl Gustav Carus Dresden
,
Julio Licinio
3   SUNY Upstate Medical University
,
Stefan Bornstein
1   Medizinische Klinik und Poliklinik III, Universitätsklinikum Carl Gustav Carus Dresden
› Institutsangaben
› Weitere Informationen
Auch verfügbar auf
   Lizenzen und Reprints

ZUSAMMENFASSUNG

Als Hausärzte und Diabetologen werden wir in den nächsten Jahren mit den Langzeitfolgen der Pandemie zu tun haben. Neben der Viruserkrankung selbst haben die Maßnahmen zur Pandemiebekämpfung bisher noch nicht absehbare Kollateralschäden verursacht. Berichte und Studien aus allen Ländern, in denen es zu Lockdowns, Ausgangssperren, Homeoffice und Schul- bzw. Kitaschließungen kam, zeigen eine signifikante Zunahme an Übergewicht, Essstörungen, Depressionen und Angststörungen in allen Bevölkerungs- und Altersgruppen. Hierbei sind sowohl die Infizierten als auch die Nichtinfizierten betroffen. Die damit zusammenhängenden Langzeitfolgen werden unser Gesundheitssystem nachhaltig beanspruchen. Besonders bedenklich ist dabei die Tatsache, dass insbesondere die jetzige Pandemie auf die bereits vorbestehende „Pandemie“ von Übergewicht und Diabetes aufgebaut hat. Wir erzeugen damit eine weitere Zunahme der größten Risikogruppe für schwere Verläufe der Infektionskrankheiten in der Zukunft. Daher sind wir nun alle, ob im primären oder tertiären Teil der Krankenversorgungstätigkeit gefordert, dieser Post-Corona-Welle an metabolischen und mentalen Komplikationen zu begegnen. Als Ärzte müssen wir auf diese Folgen hinweisen und ausreichend Ressourcen zur Versorgung dieser dramatischen „Nachwehen“ der Pandemie schaffen. Daher ist es von großer Bedeutung, das Bewusstsein für die Schnittstelle zwischen mentalen Krankheiten, Diabetes und COVID-19 zu stärken. Da sich die Symptome von Post-COVID, Diabetes und Depression überschneiden können, besteht schließlich Bedarf an der Ausbildung von Fachpersonal in der Behandlung dieser Komorbiditäten.



Publikationsverlauf

Artikel online veröffentlicht:
24. Februar 2022

© 2022. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • Literatur

  • 1 GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet 2020; 396: 1204-1222
    CrossrefPubMedSuche in Google Scholar
  • 2 Mekonen T, Chan GCK, Connor JP. et al Estimating the global treatment rates for depression: A systematic review and meta-analysis. J Affect Disord 2021; 295: 1234-1242
    CrossrefPubMedSuche in Google Scholar
  • 3 Baker RE, Mahmud AS, Miller IF. et al Infectious disease in an era of global change. Nat Rev Microbiol 2021: 1-13
    Suche in Google Scholar
  • 4 Steenblock C, Schwarz PEH, Ludwig B. et al COVID-19 and metabolic disease: mechanisms and clinical management. Lancet Diabetes Endocrinol 2021; 9: 786-798
    CrossrefPubMedSuche in Google Scholar
  • 5 Lotfaliany M, Bowe SJ, Kowal P. et al Depression and chronic diseases: Co-occurrence and communality of risk factors. J Affect Disord 2018; 241: 461-468
    CrossrefPubMedSuche in Google Scholar
  • 6 Saeedi P, Petersohn I, Salpea P. et al and Committee IDFDA. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9(th) edition. Diabetes Res Clin Pract 2019; 157: 107843
    CrossrefPubMedSuche in Google Scholar
  • 7 Pouwer F, Schram MT, Iversen MM. et al How 25 years of psychosocial research has contributed to a better understanding of the links between depression and diabetes. Diabet Med 2020; 37: 383-392
    CrossrefPubMedSuche in Google Scholar
  • 8 Abdel-Bakky MS, Amin E, Faris TM, Abdellatif AAH. Mental depression: Relation to different disease status, newer treatments and its association with COVID-19 pandemic (Review). Mol Med Rep 2021; 24: 839
    CrossrefPubMedSuche in Google Scholar
  • 9 Khaledi M, Haghighatdoost F, Feizi A, Aminorroaya A. The prevalence of comorbid depression in patients with type 2 diabetes: an updated systematic review and meta-analysis on huge number of observational studies. Acta Diabetol 2019; 56: 631-650
    CrossrefPubMedSuche in Google Scholar
  • 10 Messina R, Iommi M, Rucci P. et al Is it time to consider depression as a major complication of type 2 diabetes? Evidence from a large population-based cohort study. Acta Diabetol 2022; 59: 95-104
    CrossrefPubMedSuche in Google Scholar
  • 11 Roy T, Lloyd CE. Epidemiology of depression and diabetes: a systematic review. J Affect Disord 2012; 142 Suppl S8-S21
    CrossrefPubMedSuche in Google Scholar
  • 12 Wang F, Wang S, Zong QQ. et al Prevalence of comorbid major depressive disorder in Type 2 diabetes: a meta-analysis of comparative and epidemiological studies. Diabet Med 2019; 36: 961-969
    CrossrefPubMedSuche in Google Scholar
  • 13 Knol MJ, Twisk JW, Beekman AT. et al Depression as a risk factor for the onset of type 2 diabetes mellitus. A meta-analysis. Diabetologia 2006; 49: 837-845
    CrossrefPubMedSuche in Google Scholar
  • 14 Rotella F, Mannucci E. Depression as a risk factor for diabetes: a meta-analysis of longitudinal studies. J Clin Psychiatry 2013; 74: 31-37
    CrossrefPubMedSuche in Google Scholar
  • 15 Holt RI, de Groot M, Golden SH. Diabetes and depression. Curr Diab Rep 2014; 14: 491
    CrossrefPubMedSuche in Google Scholar
  • 16 Hoogendoorn CJ, Roy JF, Gonzalez JS. Shared Dysregulation of Homeostatic Brain-Body Pathways in Depression and Type 2 Diabetes. Curr Diab Rep 2017; 17: 90
    CrossrefPubMedSuche in Google Scholar
  • 17 Berger I, Werdermann M, Bornstein SR, Steenblock C. The adrenal gland in stress – adaptation on a cellular level. J Steroid Biochem Mol Biol 2019; 190: 198-206
    CrossrefPubMedSuche in Google Scholar
  • 18 McEwen BS. Allostasis and allostatic load: implications for neuropsychopharmacology. Neuropsychopharmacology 2000; 22: 108-124
    CrossrefPubMedSuche in Google Scholar
  • 19 Belvederi Murri M, Pariante C, Mondelli V. et al HPA axis and aging in depression: systematic review and meta-analysis. Psychoneuroendocrinology 2014; 41: 46-62
    CrossrefPubMedSuche in Google Scholar
  • 20 Stetler C, Miller GE. Depression and hypothalamic-pituitary-adrenal activation: a quantitative summary of four decades of research. Psychosom Med 2011; 73: 114-126
    CrossrefPubMedSuche in Google Scholar
  • 21 Bellass S, Lister J, Kitchen CEW. et al Living with diabetes alongside a severe mental illness: A qualitative exploration with people with severe mental illness, family members and healthcare staff. Diabet Med 2021; 38: e14562
    CrossrefPubMedSuche in Google Scholar
  • 22 Simayi A, Mohemaiti P. Risk and protective factors of co-morbid depression in patients with type 2 diabetes mellitus: a meta analysis. Endocr J 2019; 66: 793-805
    CrossrefPubMedSuche in Google Scholar
  • 23 Fung ACH, Tse G, Cheng HL. et al Depressive Symptoms, Co-Morbidities, and Glycemic Control in Hong Kong Chinese Elderly Patients With Type 2 Diabetes Mellitus. Front Endocrinol (Lausanne) 2018; 9: 261
    CrossrefPubMedSuche in Google Scholar
  • 24 Boucher J, Kleinridders A, Kahn CR. Insulin receptor signaling in normal and insulin-resistant states. Cold Spring Harb Perspect Biol 2014; 6: a009191
    CrossrefPubMedSuche in Google Scholar
  • 25 Esser N, Legrand-Poels S, Piette J. et al Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes. Diabetes Res Clin Pract 2014; 105: 141-150
    CrossrefPubMedSuche in Google Scholar
  • 26 Bornstein SR, Rubino F, Ludwig B. et al Consequences of the COVID-19 pandemic for patients with metabolic diseases. Nat Metab 2021; 3: 289-292
    CrossrefPubMedSuche in Google Scholar
  • 27 Gregory JM, Slaughter JC, Duffus SH. et al COVID-19 Severity Is Tripled in the Diabetes Community: A Prospective Analysis of the Pandemic’s Impact in Type 1 and Type 2 Diabetes. Diabetes Care 2021; 44: 526-532
    CrossrefPubMedSuche in Google Scholar
  • 28 Khunti K, Del Prato S, Mathieu C. et al COVID-19, Hyperglycemia, and New-Onset Diabetes. Diabetes Care 2021; 44: 2645-2655
    CrossrefPubMedSuche in Google Scholar
  • 29 Alsadhan I, Alruwashid S, Alhamad M. et al Diabetic ketoacidosis precipitated by Coronavirus disease 2019 infection: Case series. Curr Ther Res Clin Exp 2020; 93: 100609
    CrossrefPubMedSuche in Google Scholar
  • 30 Heaney AI, Griffin GD, Simon EL. Newly diagnosed diabetes and diabetic ketoacidosis precipitated by COVID-19 infection. Am J Emerg Med 2020; 38: 2491 e3-2491 e4
    CrossrefPubMedSuche in Google Scholar
  • 31 Hollstein T, Schulte DM, Schulz J. et al Autoantibody-negative insulin-dependent diabetes mellitus after SARS-CoV-2 infection: a case report. Nat Metab 2020; 2: 1021-1024
    CrossrefPubMedSuche in Google Scholar
  • 32 Li J, Wang X, Chen J. et al COVID-19 infection may cause ketosis and ketoacidosis. Diabetes Obes Metab 2020; 22: 1935-1941
    CrossrefPubMedSuche in Google Scholar
  • 33 Montefusco L, Ben Nasr M. et al Acute and long-term disruption of glycometabolic control after SARS-CoV-2 infection. Nat Metab 2021; 3: 774-785
    Suche in Google Scholar
  • 34 Naguib MN, Raymond JK, Vidmar AP. New onset diabetes with diabetic ketoacidosis in a child with multisystem inflammatory syndrome due to COVID-19. J Pediatr Endocrinol Metab 2021; 34: 147-150
    CrossrefPubMedSuche in Google Scholar
  • 35 Rubino F, Amiel SA, Zimmet P. et al New-Onset Diabetes in Covid-19. N Engl J Med 2020; 383: 789-790
    CrossrefPubMedSuche in Google Scholar
  • 36 Laurenzi A, Caretto A, Molinari C. et al No evidence of long-term disruption of glycometabolic control after SARS-CoV-2 infection. J Clin Endocrinol Metab. 2021
    Suche in Google Scholar
  • 37 Muller JA, Gross R, Conzelmann C. et al SARS-CoV-2 infects and replicates in cells of the human endocrine and exocrine pancreas. Nat Metab 2021; 3: 149-165
    Suche in Google Scholar
  • 38 Steenblock C, Richter S, Berger I. et al Viral infiltration of pancreatic islets in patients with COVID-19. Nat Commun 2021; 12: 3534
    CrossrefPubMedSuche in Google Scholar
  • 39 Wu CT, Lidsky PV, Xiao Y. et al SARS-CoV-2 infects human pancreatic beta cells and elicits beta cell impairment. Cell Metab 2021; 33: 1565-1576
    CrossrefPubMedSuche in Google Scholar
  • 40 Zinserling VA, Bornstein SR, Narkevich TA. et al Stillborn child with diffuse SARS-CoV-2 viral infection of multiple organs. IDCases 2021; 26: e01328
    CrossrefPubMedSuche in Google Scholar
  • 41 Ornell F, Schuch JB, Sordi AO, Kessler FHP. „Pandemic fear“ and COVID-19: mental health burden and strategies. Braz J Psychiatry 2020; 42: 232-235
    CrossrefPubMedSuche in Google Scholar
  • 42 Steenblock C, Todorov V, Kanczkowski W. et al Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the neuroendocrine stress axis. Mol Psychiatry 2020; 25: 1611-1617
    CrossrefPubMedSuche in Google Scholar
  • 43 Cena H, Fiechtner L, Vincenti A. et al COVID-19 Pandemic as Risk Factors for Excessive Weight Gain in Pediatrics: The Role of Changes in Nutrition Behavior. A Narrative Review. Nutrients 2021; 13: 4255
    CrossrefPubMedSuche in Google Scholar
  • 44 Dun Y, Ripley-Gonzalez JW, Zhou N. et al Weight gain in Chinese youth during a 4-month COVID-19 lockdown: a retrospective observational study. BMJ Open 2021; 11: e052451
    CrossrefPubMedSuche in Google Scholar
  • 45 Kang HM, Jeong DC, Suh BK, Ahn MB. The Impact of the Coronavirus Disease-2019 Pandemic on Childhood Obesity and Vitamin D Status. J Korean Med Sci 2021; 36: e21
    CrossrefPubMedSuche in Google Scholar
  • 46 Gilsbach S, Herpertz-Dahlmann B, Konrad K. Psychological Impact of the COVID-19 Pandemic on Children and Adolescents With and Without Mental Disorders. Front Public Health 2021; 9: 679041
    CrossrefPubMedSuche in Google Scholar
  • 47 Ocampo Gonzalez AA, Castillo Garcia JF, Pabon Sandoval LC. et al Depressive symptomatology in adults during the COVID-19 pandemic. J Investig Med 2022; 70: 436-445
    CrossrefPubMedSuche in Google Scholar
  • 48 Werner AM, Tibubos AN, Mulder LM. et al The impact of lockdown stress and loneliness during the COVID-19 pandemic on mental health among university students in Germany. Sci Rep 2021; 11: 22637
    CrossrefPubMedSuche in Google Scholar
  • 49 Jin Y, Sun T, Zheng P, An J. Mass quarantine and mental health during COVID-19: A meta-analysis. J Affect Disord 2021; 295: 1335-1346
    CrossrefPubMedSuche in Google Scholar
  • 50 Docherty S, Haskell-Ramsay CF, McInnes L, Wetherell MA. The Effects of COVID-19 Lockdown on Health and Psychosocial Functioning in Older Adults Aged 70 and Over. Gerontol Geriatr Med. 2021 7. 23337214211039974
    Suche in Google Scholar
  • 51 Prekazi L, Hajrullahu V, Bahtiri S. et al The Impact of Coping Skills in Post-traumatic Growth of Healthcare Providers: When Mental Health Is Deteriorating Due to COVID-19 Pandemic. Frontiers in Psychology 2021: 12
    Suche in Google Scholar
  • 52 Bulkes NZ, Davis K, Kay B, Riemann BC. Comparing efficacy of telehealth to in-person mental health care in intensive-treatment-seeking adults. J Psychiatr Res 2022; 145: 347-352
    CrossrefPubMedSuche in Google Scholar
  • 53 Rogers JP, Chesney E, Oliver D. et al Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic. Lancet Psychiatry 2020; 7: 611-627
    CrossrefPubMedSuche in Google Scholar
  • 54 Liu J, Li S, Liu J. et al Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients. EBioMedicine 2020; 55: 102763
    CrossrefPubMedSuche in Google Scholar
  • 55 Bourmistrova NW, Solomon T, Braude P. et al Long-term effects of COVID-19 on mental health: A systematic review. J Affect Disord 2021; 299: 118-125
    CrossrefPubMedSuche in Google Scholar
  • 56 Dotan A, Shoenfeld Y. Post-COVID syndrome: the aftershock of SARS-CoV-2. Int J Infect Dis 2021; 114: 233-235
    CrossrefPubMedSuche in Google Scholar
  • 57 Splinter MJ, Velek P, Ikram MK. et al Prevalence and determinants of healthcare avoidance during the COVID-19 pandemic: A population-based cross-sectional study. PLoS Med 2021; 18: e1003854
    CrossrefPubMedSuche in Google Scholar
  • 58 Morens DM, Fauci AS. Emerging infectious diseases: threats to human health and global stability. PLoS Pathog 2013; 9: e1003467
    CrossrefPubMedSuche in Google Scholar
  • 59 Tucci V, Moukaddam N, Meadows J. et al The Forgotten Plague: Psychiatric Manifestations of Ebola, Zika, and Emerging Infectious Diseases. J Glob Infect Dis 2017; 9: 151-156
    CrossrefPubMedSuche in Google Scholar
  • 60 Abas MA.. Combining active ingredients to treat depression in the wake of COVID-19. Lancet Psychiatry. 2021
    Suche in Google Scholar
  • 61 Ai X, Yang J, Lin Z. Mental Health and the Role of Physical Activity During the COVID-19 Pandemic. Front Psychol 2021; 12: 759987
    CrossrefPubMedSuche in Google Scholar
  • 62 Metoki H. (2021) The Significance of Observing the Risk of Non-communicable Diseases after Large-scale Disasters and Communicable Disease Epidemics. JMA J 2021; 4: 305-310
    CrossrefPubMedSuche in Google Scholar